Conduit Pharmaceuticals Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
CDT, CDTTW on Nasdaq
Industry
Pharmaceutical Preparations
Location
4995 Murphy Canyon Road, Suite 300, San Diego, CA

There are no Buy or Sell transactions made by insiders since 9/13/2023

Conduit Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jack Heilbron Former CEO,director&10% owner $8.15M Sep 22, 2023
David Tapolczay Chief Executive Officer, Director $1.64M Apr 22, 2024
James Bligh Interim CFO, Director $1.23M Jun 11, 2024
Chele Chiavacci Farley Director $531K Jun 11, 2024
Freda C. Lewis-Hall Director $358K Apr 22, 2024
Faith L. Charles Director $358K Dec 1, 2023
Jennifer Isacoff McNealey Director $0 May 13, 2024
Nirland Ltd 10%+ Owner Aug 6, 2024
Andrew Regan Director, 10%+ Owner Sep 22, 2023
Adam Sragovicz Chief Financial Officer May 15, 2024
Francis Knuettel II Director Feb 2, 2022
Shaolin Capital Management LLC 10%+ Owner Feb 3, 2023
Richard E. Feinberg Director Feb 2, 2022
Edwin Bentzen Chief Accounting Officer Feb 2, 2022
Murphy Canyon Acquisition Sponsor, LLC 10%+ Owner Feb 2, 2022

Recent Insider Transactions by Companies or Individuals for Conduit Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.